LHRH as a growth-inhibitory factor in prostatic tumor cells: Possible mechanism of action

Endocrine-Related Cancer

Volumn 3, Issue 3, 1996, Pages 211-216

  Limonta, P ^a   Moretti, R M ^a   Montagnani Marelli, M ^a   Dondi, D ^a   Motta, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GONADORELIN AGONIST; GOSERELIN; MITOGENIC AGENT;

ANIMAL CELL; BINDING SITE; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION; MALE; NONHUMAN; ONCOGENE C FOS; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; RAT; REVIEW;

EID: 0029909634     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0030211     Document Type: Review

References (32)

1. Adelman J, Mason AJ, Hayflyck JS & Seeburg PH 1986 Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. Proceedings of the National Academy of Sciences of the USA 83 179-183.
2. Berns EMJJ, De Boer W & Mulder E 1983 Androgen dependent growth regulation and the release of specific proteins by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9 247-259.
3. Carpenter G & Cohen S 1990 Epidermal growth factor. Journal of Biological Chemistry 265 7709-7712.
4. Cohen P, Peehl D, Lamson G & Rosenfeld RR 1991 Insulin-like growth factors, IGF receptors and IGF- binding proteins in primary cultures of prostate epithelial cells. Journal of Clinical Endocrinology and Metabolism 73 401-407.
5. Connolly JM & Rose DP 1990 Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human cancer cell line. Prostate 16 209-218.
6. Connolly JM & Rose DP 1991 Autocrine regulation of DU 145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19 173-180.
7. Connolly JM & Rose DP 1994 Regulation of DU 145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate 24 167-175.
8. Crawford ED, DeAntonio EP, Labrie F, Schroder FH & Geller J 1995 Endocrine therapy of prostate cancer, optimal form and appropriate timing. Journal of Clinical Endocrinology and Metabolism 80 1062-1078.
9. Culig Z, Klocher H, Eberle J, Kaspar F, Hobisch A, Cronauer MV & Bartsh G 1993 DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22 11-22.
10. Dondi D, Limonta P, Moretti RM, Montagnani Marelli M, Garattini E & Motta M 1994 Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory loop. Cancer Research 54 4091-4095.
11. Fantl WJ, Johnson DE & Williams LT 1993 Signalling by receptor tyrosine kinases. Annual Review of Biochemistry 62 453-481.
12. Helle SI & Lonning PE 1995 Insulin-like growth factors in breast and prostatic cancer. Endocrine-Related Cancer 2 153-169.
13. Henttu P, Liao S & Vihko P 1992 Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130 766-772.
14. Herschman HR 1991 Primary response genes induced by growth factors and tumor promoters. Annual Review of Biochemistry 60 281-319.
15. Hodges CV 1979 Hormone therapy of prostatic cancer. In Endocrinology of Cancer, vol. II, pp 57-67. Ed DP Rose. Boca Raton: CRC Press.
16. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA & Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Research 43 1809-1818.
17. Izumi H, Ono M, Ushiro S, Kohno K, Kung H-F & Kuwano M 1994 Cross talk of tumor necrosis factor-α and epidermal growth factor in human microvascular endothelial cells. Experimental Cell Research 214 654-662.
18. Knabbe C, Klein H, Zugmaier G & Voigt K-D 1993 Hormonal regulation of transforming growth factor β-2 expression in human prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 47 137-142.
19. Kozlowski JM & Grayhack JT 1987 Carcinoma of the prostate. In Adult and Pediatric Urology, pp 1126-1219. Eds JY Gillenwater, JT Grayhack, SS Howards & JW Duckett. Chicago: Year Book Medical Publishers.
20. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 680-685.
21. Limonta P, Dondi D, Moretti RM, Maggi R & Motta M 1992 Antiproliferative effects of luteinizing hormone- releasing hormone agonists on the human prostatic cancer cell line LNCaP. Journal of Clinical Endocrinology and Metabolism 75 207-212.
22. Limonta P, Moretti RM, Dondi D, Montagnani Marelli M & Motta M 1994 The EGF/TGFα system as an autocrine growth stimulatory loop in LNCaP cells. Endocrine- Related Cancer 1 (3) 5-13.
23. MacDonald A & Habib FK 1992 Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. British Journal of Cancer 65 177-182.
24. MacGrogan D, Saint-Andre JP & Dicou E 1992 Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. Journal of Neurochemistry 59 1381-1391.
25. Qayum A, Gullick W, Clayton RC, Sikora K & Waxman J 1990 The effects of gonadotrophin releasing hormone analogues in prostatic cancer cell lines. British Journal of Cancer 62 96-99.
26. Rambaldi A, Young DC & Griffin JD 1987 Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 69 1409-1413.
27. Schuurmans ALG, Bolt J, Veldscholte J & Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. Journal of Steroid Biochemistry and Molecular Biology 40 193-197.
28. Stone KR, Mickey DD, Wunderli H, Mickey GH & Paulson DF 1978 Isolation of a human prostatic carcinoma cell line (DU 145). International Journal of Cancer 21 274-281.
29. Ullrich A & Schlessinger J 1990 Signal transduction by receptors with tyrosine kinase activity. Cell 61 203-212.
30. Ware JL 1993 Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer and Metastasis Reviews 12 287-301.
31. Wilding 1992 The importance of steroid hormones in prostate cancer. Cancer Surveys 14 113-130.
32. Zuck B, Goepfert C, Nedlin-Chittka A, Sohrt K, Voigt K-D & Knabbe C 1992 Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP. Journal of Steroid Biochemistry and Molecular Biology 41 659-663.